CuraTech was established in September 2023 to distribute Revita, an Australian-made amniotic tissue allograft derived from human placenta, manufactured by Surgical BioFix in Brisbane. Our distribution network extends across Australia, New Zealand, and the South Pacific.
Amniotic membrane allografts are widely used in the United States across a variety of medical applications, including as wound coverings for chronic and acute wounds and as barrier membranes in numerous surgical specialties. With Revita, we aim to offer Australian patients access to these cutting-edge developments in regenerative medicine.